![Michael Kalb](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Kalb
Director of Finance/CFO at
CATALYST PHARMACEUTICALS, INC.
Net worth: 426 758 $ as of 31/05/2026
Profile
Michael W.
Kalb is Chief Financial Officer & Executive Vice President at Catalyst Pharmaceuticals, Inc. since 2024.
Former roles include Executive VP, Chief Financial & Accounting Officer at CinCor Pharma, Inc. from 2022 to 2023; Chief Financial Officer at IPI Legacy Liquidation Co. in 2023; Chief Financial Officer & Senior Vice President at Amarin Corp.
Plc from 2016 to 2022; Chief Financial & Accounting Officer, Group VP at Taro Pharmaceutical Industries Ltd. from 2013 to 2016; Chief Financial Officer at Taro Pharmaceuticals U.S.A., Inc.; and Director-Accounting & Financial Consulting Group at Huron Consulting Group, Inc. Education includes undergraduate studies at State University of New York at Albany.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 27/04/2026 | 13,665 ( 0.01% ) | 426 758 $ | 31/05/2026 |
Michael Kalb active positions
| Companies | Position | Start |
|---|---|---|
| CATALYST PHARMACEUTICALS, INC. | Director of Finance/CFO | 01/01/2024 |
Former positions of Michael Kalb
| Companies | Position | End |
|---|---|---|
| IPI LEGACY LIQUIDATION CO | Director of Finance/CFO | 31/12/2023 |
| CINCOR PHARMA, INC. | Director of Finance/CFO | 01/03/2023 |
| AMARIN CORPORATION PLC | Director of Finance/CFO | 20/06/2022 |
| TARO PHARMACEUTICAL INDUSTRIES LTD. | Director of Finance/CFO | 29/06/2016 |
| HURON CONSULTING GROUP INC. | Comptroller/Controller/Auditor | - |
Training of Michael Kalb
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
43
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Amarin Corp. Plc
 Amarin Corp. Plc Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops and commercializes therapeutics to improve cardiovascular health | Health Technology |
Taro Pharmaceutical Industries Ltd.
 Taro Pharmaceutical Industries Ltd. Medical/Nursing ServicesHealth Services Operates as a healthcare company that engages in therapies and generic medicines | Health Services |
Huron Consulting Group, Inc.
 Huron Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides healthcare, business advisory and education services | Commercial Services |
Catalyst Pharmaceuticals, Inc.
 Catalyst Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets novel medicines for patients living with rare diseases | Health Technology |
Impel Pharmaceuticals, Inc.
 Impel Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a late-stage biopharmaceutical company focused on developing transformative therapies for central nervous system disorders | Health Technology |
State University of New York at Albany
 State University of New York at Albany Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Taro Pharmaceuticals U.S.A., Inc.
 Taro Pharmaceuticals U.S.A., Inc. Pharmaceuticals: GenericHealth Technology Manufactures and sells generic pharmaceutical products | Health Technology |
CinCor Pharma, Inc.
 CinCor Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops and trades medicines for cardiovascular, metabolic & kidney diseases | Health Technology |
- Stock Market
- Insiders
- Michael Kalb
